
                                SEQUENCE LISTING

<110> Soares, Christopher J.

<120> USE OF CGRP RECEPTOR ANTAGONISTS IN
  NEUROPROTECTION AND NEUROLOGICAL DISORDERS
  

<130> CSOAR.003WO

<150> 62/383334           
<151> 2016-09-02  

<160> 58

<170> FastSEQ for Windows Version 4.0

<210> 1
<211> 32
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 1
Ala Cys Asp Thr Ala Ala Cys Val Leu Gly Arg Leu Ser Gln Glu Leu
 1               5                  10                  15      
His Arg Leu Gln Thr Tyr Pro Arg Thr Asn Val Gly Ser Lys Ala Phe
            20                  25                  30          


<210> 2
<211> 32
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 2
Ala Cys Asp Thr Ala Ser Cys Val Leu Gly Arg Leu Ser Gln Glu Leu
 1               5                  10                  15      
His Arg Leu Gln Thr Tyr Pro Arg Thr Asn Val Gly Ser Lys Ala Phe
            20                  25                  30          


<210> 3
<211> 32
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 3
Ala Cys Asp Thr Ala Val Cys Val Leu Gly Arg Leu Ser Gln Glu Leu
 1               5                  10                  15      
His Arg Leu Gln Thr Tyr Pro Arg Thr Asn Val Gly Ser Lys Ala Phe
            20                  25                  30          


<210> 4
<211> 32
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 4
Ala Cys Asn Thr Ala Ala Cys Val Leu Gly Arg Leu Ser Gln Glu Leu
 1               5                  10                  15      
His Arg Leu Gln Thr Tyr Pro Arg Thr Asn Val Gly Ser Lys Ala Phe
            20                  25                  30          


<210> 5
<211> 32
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 5
Ala Cys Val Leu Gly Ala Cys Val Leu Gly Arg Leu Ser Gln Glu Leu
 1               5                  10                  15      
His Arg Leu Gln Thr Tyr Pro Arg Thr Asn Val Gly Ser Lys Ala Phe
            20                  25                  30          


<210> 6
<211> 32
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 6
Ala Cys Arg Phe Gly Ala Cys Val Leu Gly Arg Leu Ser Gln Glu Leu
 1               5                  10                  15      
His Arg Leu Gln Thr Tyr Pro Arg Thr Asn Val Gly Ser Lys Ala Phe
            20                  25                  30          


<210> 7
<211> 32
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 7
Ala Cys Asn Leu Ser Ala Cys Val Leu Gly Arg Leu Ser Gln Glu Leu
 1               5                  10                  15      
His Arg Leu Gln Thr Tyr Pro Arg Thr Asn Val Gly Ser Lys Ala Phe
            20                  25                  30          


<210> 8
<211> 32
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 8
Cys Ser Asn Thr Ala Ala Cys Val Leu Gly Arg Leu Ser Gln Glu Leu
 1               5                  10                  15      
His Arg Leu Gln Thr Tyr Pro Arg Thr Asn Val Gly Ser Lys Ala Phe
            20                  25                  30          


<210> 9
<211> 32
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 9
Ala Cys Asp Thr Ala Leu Cys Val Leu Gly Arg Leu Ser Gln Glu Leu
 1               5                  10                  15      
His Arg Leu Gln Thr Tyr Pro Arg Thr Asn Val Gly Ser Lys Ala Phe
            20                  25                  30          


<210> 10
<211> 32
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 10
Ala Cys Asp Thr Ala Ile Cys Val Leu Gly Arg Leu Ser Gln Glu Leu
 1               5                  10                  15      
His Arg Leu Gln Thr Tyr Pro Arg Thr Asn Val Gly Ser Lys Ala Phe
            20                  25                  30          


<210> 11
<211> 32
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 11
Ala Cys Asn Leu Ser Val Cys Val Leu Gly Arg Leu Ser Gln Glu Leu
 1               5                  10                  15      
His Arg Leu Gln Thr Tyr Pro Arg Thr Asn Val Gly Ser Lys Ala Phe
            20                  25                  30          


<210> 12
<211> 32
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 12
Cys Ser Asn Thr Ala Val Cys Val Leu Gly Arg Leu Ser Gln Glu Leu
 1               5                  10                  15      
His Arg Leu Gln Thr Tyr Pro Arg Thr Asn Val Gly Ser Lys Ala Phe
            20                  25                  30          


<210> 13
<211> 31
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 13
Ala Cys Asn Leu Ser Ala Cys Val Leu Gly Arg Leu Ser Gln Glu Leu
 1               5                  10                  15      
His Arg Leu Gln Thr Tyr Pro Thr Asn Thr Gly Ser Gly Thr Pro
            20                  25                  30      


<210> 14
<211> 32
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 14
Ala Cys Val Leu Gly Ala Cys Val Leu Gly Arg Leu Ser Gln Glu Leu
 1               5                  10                  15      
His Arg Leu Gln Thr Tyr Pro Val Asp Pro Ser Ser Pro His Ser Tyr
            20                  25                  30          


<210> 15
<211> 37
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 15
Ala Cys Asp Thr Ala Ala Cys Val Thr His Arg Leu Ala Gly Leu Leu
 1               5                  10                  15      
Ser Arg Ser Gly Gly Val Val Lys Asn Asn Phe Val Pro Thr Asn Val
            20                  25                  30          
Gly Ser Lys Ala Phe
        35          


<210> 16
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<220> 
<221> VARIANT        
<222> (1)...(1)
<223> Xaa = selected from the group consisting Ala, Cys,
      Gly, Ile, Leu, Met, Phe, Pro, Trp, and Val

<220> 
<221> VARIANT        
<222> (2)...(2)
<223> Xaa = selected from the group consisting of Cys,
      Ser, and Tyr

<220> 
<221> VARIANT        
<222> (3)...(3)
<223> Xaa = selected from the group consisting of Arg,
      Asn, Asp, Cys, Glu, Gln, His, Lys, Ser, Thr, Tyr,
      and Val

<220> 
<221> VARIANT        
<222> (4)...(4)
<223> Xaa = selected from the group consisting of Arg,
      Asn, Asp, Glu, Gln, His, Leu, Lys, Phe, Ser, Thr,
      Tyr, and Val


<220> 
<221> VARIANT        
<222> (5)...(5)
<223> Xaa = selected from the group consisting of Ala,
      Gly, Ile, Leu, Met, Phe, Ser, Typ, and Val


<220> 
<221> VARIANT        
<222> (6)...(6)
<223> Xaa = selected from the group consisting of Ala,
      Gly, Ile, Leu, Met, Phe, Ser, Typ, and Val


<220> 
<221> VARIANT        
<222> (7)...(7)
<223> Xaa = Cys

<400> 16
Xaa Xaa Xaa Xaa Xaa Xaa Xaa
 1               5          


<210> 17
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 17
Ala Cys Asp Thr Ala Ala Cys
 1               5          


<210> 18
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 18
Ala Cys Asp Thr Ala Ser Cys
 1               5          


<210> 19
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 19
Ala Cys Asp Thr Ala Val Cys
 1               5          


<210> 20
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 20
Ala Cys Asn Thr Ala Ala Cys
 1               5          


<210> 21
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 21
Ala Cys Val Leu Gly Ala Cys
 1               5          


<210> 22
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 22
Ala Cys Arg Phe Gly Ala Cys
 1               5          


<210> 23
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 23
Ala Cys Asp Leu Ser Ala Cys
 1               5          


<210> 24
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 24
Ala Cys Asn Leu Ser Ala Cys
 1               5          


<210> 25
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 25
Cys Ser Asn Thr Ala Ala Cys
 1               5          


<210> 26
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 26
Ala Cys Asp Thr Ala Leu Cys
 1               5          


<210> 27
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 27
Ala Cys Asp Thr Ala Ile Cys
 1               5          


<210> 28
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 28
Ala Cys Asp Thr Ala Leu Cys
 1               5          


<210> 29
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 29
Ala Cys Asp Thr Ala Ile Cys
 1               5          


<210> 30
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 30
Ala Cys Asp Leu Ser Val Cys
 1               5          


<210> 31
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 31
Ala Cys Asp Leu Ser Val Cys
 1               5          


<210> 32
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 32
Ala Cys Asn Leu Ser Val Cys
 1               5          


<210> 33
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 33
Cys Ser Asn Thr Ala Val Cys
 1               5          


<210> 34
<211> 19
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 34
Val Leu Gly Arg Leu Ser Gln Glu Leu His Arg Leu Gln Thr Tyr Pro
 1               5                  10                  15      
Arg Thr Asn
            


<210> 35
<211> 19
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 35
Val Leu Gly Lys Leu Ser Gln Glu Leu His Lys Leu Gln Thr Tyr Pro
 1               5                  10                  15      
Arg Thr Asn
            


<210> 36
<211> 19
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 36
Val Leu Gly Lys Leu Ser Gln Glu Leu His Lys Leu Gln Thr Tyr Pro
 1               5                  10                  15      
Arg Thr Asp
            


<210> 37
<211> 19
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 37
Val Leu Gly Lys Leu Ser Gln Glu Leu His Lys Leu Gln Thr Phe Pro
 1               5                  10                  15      
Arg Thr Asn
            


<210> 38
<211> 19
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 38
Val Leu Gly Lys Leu Ser Gln Asp Ile His Lys Leu Gln Thr Tyr Pro
 1               5                  10                  15      
Arg Thr Asn
            


<210> 39
<211> 19
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 39
Val Leu Gly Lys Leu Ser Gln Glu Leu His Lys Met Gln Thr Tyr Pro
 1               5                  10                  15      
Arg Thr Asp
            


<210> 40
<211> 19
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 40
Leu Leu Gly Lys Leu Ser Gln Glu Leu His Arg Leu Gln Thr Tyr Thr
 1               5                  10                  15      
Arg Thr Asp
            


<210> 41
<211> 19
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 41
Val Leu Gly Lys Leu Ser Gln Asp Leu His Lys Leu Gln Thr Phe Pro
 1               5                  10                  15      
Arg Thr Asp
            


<210> 42
<211> 19
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 42
Met Leu Gly Lys Leu Ser Gln Asp Leu His Lys Leu Gln Thr Phe Pro
 1               5                  10                  15      
Arg Thr Asp
            


<210> 43
<211> 19
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 43
Val Leu Gly Lys Leu Ser Gln Asp Ile His Lys Leu Gln Thr His Pro
 1               5                  10                  15      
Arg Thr Asp
            


<210> 44
<211> 19
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 44
Val Leu Gly Lys Leu Ser Gln Asp Ile His Lys Leu Gln Thr His Pro
 1               5                  10                  15      
Arg Thr Asp
            


<210> 45
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<220> 
<221> VARIANT        
<222> (1)...(1)
<223> Xaa = selected from the group consisting of Ala,
      Gly, Ile, Leu, Met, Phe, Pro, Trp, and Val

<220> 
<221> VARIANT        
<222> (2)...(2)
<223> Xaa = selected from the group consisting of Ala,
      Gly, Ile, Leu, Met, Phe, Pro, Trp, and Val

<220> 
<221> VARIANT        
<222> (3)...(3)
<223> Xaa = selected from the group consisting of Ser
      and Tyr

<220> 
<221> VARIANT        
<222> (4)...(4)
<223> Xaa = selected from the group consisting of Arg,
      Asn, Asp, Glu, Gln, His, Lys, Ser, Thr, and Tyr


<220> 
<221> VARIANT        
<222> (5)...(5)
<223> Xaa = selected from the group consisting of Ala,
      Gly, Ile, Leu, Met, Phe, Pro, Trp, and Val


<220> 
<221> VARIANT        
<222> (6)...(6)
<223> Xaa = selected from the group consisting of Ala,
      Gly, Ile, Leu, Met, Phe, Pro, Trp, and Val

<400> 45
Xaa Xaa Xaa Xaa Xaa Xaa
 1               5      


<210> 46
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 46
Val Gly Ser Lys Ala Phe
 1               5      


<210> 47
<211> 6
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 47
Val Gly Ser Lys Ala Phe
 1               5      


<210> 48

<400> 48
 000

<210> 49
<211> 7
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<220> 
<221> VARIANT        
<222> (6)...(6)
<223> Xaa = any amino acid residue other than Thr

<400> 49
Ala Cys Asp Thr Ala Xaa Cys
 1               5          


<210> 50
<211> 16
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 50
Glu Ala Ala Ala Lys Glu Ala Ala Ala Lys Glu Ala Ala Ala Lys Ala
 1               5                  10                  15      


<210> 51
<211> 17
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 51
Ala Lys Ala Ala Ala Glu Lys Ala Ala Ala Glu Lys Ala Ala Ala Glu
 1               5                  10                  15      
Ala
    


<210> 52
<211> 16
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 52
Ala Glu Ala Ala Lys Ala Glu Ala Ala Lys Ala Glu Ala Ala Lys Ala
 1               5                  10                  15      


<210> 53
<211> 16
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 53
Ala Lys Ala Ala Glu Ala Lys Ala Ala Glu Ala Lys Ala Ala Glu Ala
 1               5                  10                  15      


<210> 54

<400> 54
 000

<210> 55

<400> 55
 000

<210> 56

<400> 56
 000

<210> 57
<211> 32
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 57
Ala Cys Asp Leu Ser Ala Cys Val Leu Gly Arg Leu Ser Gln Glu Leu
 1               5                  10                  15      
His Arg Leu Gln Thr Tyr Pro Arg Thr Asn Val Gly Ser Lys Ala Phe
            20                  25                  30          


<210> 58
<211> 32
<212> PRT
<213> Artificial Sequence

<220> 
<223> Synthetic peptide

<400> 58
Ala Cys Asp Leu Ser Val Cys Val Leu Gly Arg Leu Ser Gln Glu Leu
 1               5                  10                  15      
His Arg Leu Gln Thr Tyr Pro Arg Thr Asn Val Gly Ser Lys Ala Phe
            20                  25                  30          

